Saturday (22.10.2022) Sunday (23.10.2022) Monday (24.10.2022)
 
Großer Saal


Interactive Case Discussion

  • T. Illidge
  • J. Zijlstra
  1. Case presentation: Greyzone Lymphoma

  2. Case presentation: Anti-PD1 Failure

    • G. Collins
  3. Case presentation: COVID19 immunity in lymphoma

    • S. Mellinghoff
  4. Case presentation: Primary progressive HL

    • A. Jacob
Großer Saal


Advanced Stages

  • O. Casasnovas
  • J. Radford
  1. Why I recommend BV-AVD

    • R. Advani
  2. Why I recommend PET-guided ABVD

    • P. Johnson
  3. Why I recommend PET-adapted escalated BEACOPP

    • P. Borchmann
  4. Discussion forum: Challenging standard recommendations from a patient's, nurse's and physician's perspective

    • M. Dreyling
    • J. Richardson
    • S. Wells
  5. WS Report: Learning through International Collaboration

    • P. Borchmann
    • C. Moskowitz

+ 2 Oral Abstract presentations


Seminars and Workshops (parallel sessions)

  1. Seminar: Living beyond Lymphoma

    • L. Specht
    • F. van Leeuwen
  2. Workshop: The HL Microenvironment

    • A. Rosenwald
    • M. Shipp
  3. Joint EHA-ISHL Symposium

    • P. Borchmann
    • M. Dreyling
  4. Workshop: PET beyond Deauville

    • S. Barrington
    • M. Hutchings
    • C. Kobe
  5. Workshop: Innovation for Older Patients

    • P. Bröckelmann
    • A. Fosså
Coffee Break
Coffee Break
Großer Saal


Emerging Cellular Therapies – a Role in HL?

  • S. Ansell
  • P. Borchmann
  1. Emerging indications for cellular therapy

    • P. Borchmann
  2. tba

  3. Cellular Therapy in HL

    • B. Savoldo
Großer Saal


Special Situations in HL

  • R. Hoppe
  • M. Kersten
  1. HL in Pregnancy

    • D. Dierickx
  2. HIV-positive HL

    • O. Baiocchi
  3. alloSCT in the era of anti-PD1

    • A. Sureda
Coffee Break
Coffee Break
Coffee Break


Seminars and Workshops (parallel sessions)

  1. Seminar: Radiotherapy: Identifying the Beneficiaries

    • C. Baues
    • J. Yahalom
  2. Seminar: Learning from Pediatric HL

    • J. Friedberg
    • C. Mauz-Körholz
  3. Workshop: Bringing Liquid Biopsy to Patients

    • S. Borchmann
    • D. Rossi
  4. Workshop: NLPHL

    • M. Binkley
    • D. Eichenauer
    • S. Hartmann
  5. Workshop: Learning through International Collaboration

    • P. Borchmann
    • A. Moskowitz
Großer Saal


Living beyond Lymphoma

  • M. Björkholm
  • F. van Leeuwen
  1. TBA

  2. GHSG data on fertility, fatigue and social reintegration and the ongoing EMBrACe study

    • K. Behringer
  3. WS Report: Living beyond Lymphoma

    • L. Specht
    • F. van Leeuwen

+ 3 Oral Abstract presentations

Großer Saal


Genomics, Biology and Microenvironment

  • W. Klapper
  • R. Küppers
  1. Biological Classification of HL by Liquid Biopsy

    • S. Borchmann
  2. Single Cell Transcriptomics of HL

    • C. Steidl
  3. WS Report: Learning through International Collaboration

    • P. Borchmann
    • C. Moskowitz

+ 3 Oral Abstract presentations

Coffee Break
Coffee Break
Coffee Break
Großer Saal


Opening paths to the next chapters of lymphoma treatmen

by Beigene
  1. Welcome and Introduction to the topic

    • P. Borchmann
  2. Hodgkin’s lymphoma as a model for immuno-oncologic therapeutic approaches to lymphoma

    • P. Bröckelmann
  3. The challenge of the older patient in lymphoma therapy

    • G. Collins
  4. New trends in lymphoma therapy: future role of BTKi / CAR-T / bispecific antibodies

    • P. Zinzani
  5. Summary and farewell

    • S. Borchmann
Großer Saal


Checkpoint Inhibition in Hodgkin Lymphoma – State of the art and future perspectives

by MSD
  • P. Borchmann
  1. Firstline therapy of classical Hodgkin Lymphoma – How can immunotherapy improve outcome?

    • P. Borchmann
  2. The current role of PD-1 inhibition in the treatment of relapsed or refractory classical Hodgkin Lymphoma

    • B. von Tresckow
  3. Strategies to enhance checkpoint inhibition

    • P. Bröckelmann
Großer Saal


Bridging the gap between efficacy and toxicity in the treatment of stage IV Hodgkin lymphoma

by Takeda
  • G. Collins
  • A. Herrera
  • P. Zinzani
  1. Hot Off the Press: The Latest Data for ECHELON-1

  2. Case Study #1 Female, early-30s

  3. Case Study #2 Male, late-70s

  4. Case Study #3 Male, mid-50s

  5. Q&A

Coffee Break
Coffee Break
Coffee Break
Großer Saal


Early Stages

  • M. André
  • H. Eich
  1. Standard treatment of early-stage HL (Note: with RAPID Update)

    • J. Radford
  2. Individual risk assessment of RT in HL

    • R. Hoppe
  3. WS Report: NLPHL

    • M. Binkley
    • D. Eichenauer
    • S. Hartmann

+ 3 Oral Abstract presentations

Großer Saal


Older and Frail Patients

  • R. Cordoba
  • A. Evens
  1. Managing an Older Lymphoma Patient

    • R. Cordoba
  2. Treatment Strategies in Older HL Patients

    • A. Evens
  3. Workshop Report: Innovation for Older patients

    • P. Bröckelmann
    • A. Fosså

+ 3 Oral Abstract presentations

Großer Saal


Relapsed / Refractory HL

  • R. Advani
  • C. Moskowitz
  1. 1ˢᵗ Relapse of HL

    • C. Moskowitz
  2. Novel developments in R/R HL

    • G. Collins
  3. WS Report: PET beyond Deauville

    • S. Barrington
    • M. Hutchings
    • C. Kobe

+ 3 Oral Abstract presentations

Coffee Break
Coffee Break
Großer Saal


Closing Remarks

  1. Conference Highlights

    • R. Advani
Großer Saal


CAR T cell therapy in B Cell NHL: Status quo and future perspectives

by Bristol-Myers Squibb
  • C. Scheid
  1. Status quo of CAR T cell therapy for r/r DLBCL

    • P. Borchmann
  2. New perspective for the treatment of r/r CLL

  3. CAR T – Lessons Learned

    • C. Scheid
Großer Saal


Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma

by Takeda
  1. Welcome and introduction

    • A. Sureda
  2. Navigating Complex Treatment Decisions in R/R HL

    • T. Vassilakopoulos
  3. Challenging Case Study #1

    • M. Hutchings
  4. Learning from Real-World Evidence to Inform Treatment Decisions in R / R HL

    • A. Sureda
  5. Challenging Case Study #2

    • M. Hutchings
Großer Saal


Farewell

Coffee Break
Coffee Break
 
Großer Saal


Opening and Award Ceremony

  1. Welcoming Address

    • A. Engert
  2. Award Ceremony

    • P. Borchmann
    • S. Borchmann
    • P. Bröckelmann
    • D. Eichenauer
  3. Introduction to the Keynote Lecturer

    • V. Diehl
  4. Keynote Lecture

    • U. Sahin
Großer Saal


Immunotherapy

  • P. Armand
  • P. Zinzani
  1. New findings and new challenges since last ISHL

    • S. Ansell
  2. Vision Corner: The future of translational science in Hodgkin

    • M. Shipp
  3. Vision Corner: Best use of PD1 blockade in front-line

    • P. Bröckelmann
  4. Vision Corner: Leveraging PD1 blockade for cure

    • G. Collins

+ 2 Oral Abstract presentations

Foyer (Ground Floor)


Poster Session

Foyer (First Floor)


Welcome Reception